Alpine Immune Sciences Inc reports results for the quarter ended in December - Earnings Summary

Alpine Immune Sciences

17/03/2022 21:29

* Alpine Immune Sciences Inc  ALPN.OQ  reported a quarterly
adjusted loss of 52 cents​​ per share for the quarter ended in
December. The mean expectation of four analysts for the quarter
was for a loss of 30 cents per share.
    * Revenue fell 19.7% to $4.53 million from a year ago; 
analysts
expected $13.97 million. 
    * Alpine Immune Sciences Inc's reported EPS for the quarter
was a
loss of 52 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Alpine Immune Sciences Inc shares had fallen by 40.5% this
quarter.
    * The company reported a quarterly loss of $15.17 million.
    * Wall Street's median 12-month price target for Alpine
Immune
Sciences Inc is $21.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated March 17 at 09:29 p.m.  ​All
figures in US dollars unless otherwise stated